Winton Group
LAB icon

Winton Group’s Standard BioTools LAB Stock Holding History

Winton Group’s Portfolio LAB Stock Details LAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$214K Buy
+288,476
New +$222K 0.01% 930
2020
Q1 		– Sell
-20,568
Closed -$72K – 1475
2019
Q4 		$72K Buy
+20,568
New +$72.4K ﹤0.01% 1497

Other funds holding LAB

Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
Hollow Brook Wealth Management
Hollow Brook Wealth Management Katonah, New York $575M AUM 19.16% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $123B AUM 30.05% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
TM
Tikvah Management Charlotte, North Carolina $323M AUM 29.93% 1-Year Est. Return
Peapod Lane Capital
Peapod Lane Capital Bedford Hills, New York $134M AUM 63.91% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $73.4B AUM 32.8% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $463B AUM
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $85.7B AUM 51.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return

Winton Group's LAB Position: Q3 2026 in Review

Winton Group opened a new position in Standard BioTools (LAB) in Q3 2026: 288,476 shares worth $214K. The stake represents 0.01% of the portfolio and ranks #930 among its holdings. This is a return to the name: Winton Group previously reported a position in LAB as recently as Q4 2019.

Winton Group first reported a position in LAB in Q4 2019 and has held it in 2 quarters since. 57 funds tracked by Wall St. Rank hold LAB as of Q3 2026.

  • Winton Group held 288,476 shares of Standard BioTools worth $214K as of Q3 2026.
  • Standard BioTools was a new Winton Group position in Q3 2026.
  • Standard BioTools made up 0.01% of Winton Group's portfolio in Q3 2026, its #930 holding.
  • Winton Group first reported a position in Standard BioTools in Q4 2019 and has held it in 2 quarters since.
  • 57 funds tracked by Wall St. Rank held Standard BioTools as of Q3 2026.

Based on Winton Group's 13F filing for Q3 2026, filed 12 Nov 2026.